Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Stage III Gynecologic Cancer 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mindfulness × Gynecologic × Clear all
NCT04072406 2024-12-30

A Self-Directed Mindfulness Meditation Intervention in Gynecologic Cancer Patients

Washington University School of Medicine

Phase NA Terminated
21 enrolled
Gynecologic

Stage III Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡